{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T09:13:19Z","timestamp":1773306799425,"version":"3.50.1"},"reference-count":191,"publisher":"Elsevier","isbn-type":[{"value":"9780128021736","type":"print"}],"license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016]]},"DOI":"10.1016\/b978-0-12-802173-6.00018-6","type":"book-chapter","created":{"date-parts":[[2016,6,3]],"date-time":"2016-06-03T19:41:29Z","timestamp":1464982889000},"page":"477-502","source":"Crossref","is-referenced-by-count":1,"title":["Tackling Alzheimer\u2019s Disease by Targeting Oxidative Stress and Mitochondria"],"prefix":"10.1016","author":[{"given":"R.J.","family":"Castellani","sequence":"first","affiliation":[]},{"given":"S.C.","family":"Correia","sequence":"additional","affiliation":[]},{"given":"P.I.","family":"Moreira","sequence":"additional","affiliation":[]},{"given":"G.","family":"Perry","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0010","doi-asserted-by":"crossref","first-page":"4217","DOI":"10.1523\/JNEUROSCI.0496-05.2005","article-title":"Voluntary exercise decreases amyloid load in a transgenic model of Alzheimer\u2019s disease","volume":"25","author":"Adlard","year":"2005","journal-title":"J Neurosci"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0015","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.clinbiochem.2009.08.021","article-title":"Increased low-density lipoprotein oxidation, but not total plasma protein oxidation, in Alzheimer\u2019s disease","volume":"43","author":"Aldred","year":"2010","journal-title":"Clin Biochem"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0020","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.1582-4934.2008.00324.x","article-title":"Neuronal mitochondrial amelioration by feeding acetyl-L-carnitine and lipoic acid to aged rats","volume":"13","author":"Aliev","year":"2009","journal-title":"J Cell Mol Med"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0025","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/NEN.0b013e3181cb5af4","article-title":"Oxidative stress in the progression of Alzheimer disease in the frontal cortex","volume":"69","author":"Ansari","year":"2010","journal-title":"J Neuropath Exp Neurol"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0030","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1600-0404.2010.01412.x","article-title":"Physical exercise alleviates debilities of normal aging and Alzheimer\u2019s disease","volume":"123","author":"Archer","year":"2011","journal-title":"Acta Neurologica Scandinavica"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0035","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1007\/s11064-012-0860-8","article-title":"Effect of one-year vitamin C- and E-supplementation on cerebrospinal fluid oxidation parameters and clinical course in Alzheimer\u2019s disease","volume":"37","author":"Arlt","year":"2012","journal-title":"Neurochem Res"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0040","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1046\/j.1471-4159.2000.0751219.x","article-title":"Characterization of copper interactions with Alzheimer amyloid beta peptides: identification of an attomolar-affinity copper binding site on amyloid beta1-42","volume":"75","author":"Atwood","year":"2000","journal-title":"J Neurochem"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0045","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.clinbiochem.2006.09.005","article-title":"Determination of malondialdehyde, reduced glutathione levels and APOE4 allele frequency in late-onset Alzheimer\u2019s disease in Denizli, Turkey","volume":"40","author":"Aybek","year":"2007","journal-title":"Clin Biochem"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0050","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/jcbfm.1993.58","article-title":"Early detection of Alzheimer\u2019s disease: a statistical approach using positron emission tomographic data","volume":"13","author":"Azari","year":"1993","journal-title":"J Cerebr Blood F Metabol"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0055","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1749-6632.2001.tb03654.x","article-title":"Antihistamine agent Dimebon as a novel neuroprotector and a cognition enhancer","volume":"939","author":"Bachurin","year":"2001","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0060","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3233\/JAD-2006-9204","article-title":"Mitochondrial alterations in Alzheimer\u2019s disease","volume":"9","author":"Baloyannis","year":"2006","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0065","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nrd1330","article-title":"Neurodegenerative diseases and oxidative stress","volume":"3","author":"Barnham","year":"2004","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0070","first-page":"231","article-title":"Metals and trace elements in plasma and cerebrospinal fluid in normal aging and Alzheimer\u2019s disease","volume":"3","author":"Basun","year":"1991","journal-title":"J Neural Transm-Park Dis Dement Sect"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0075","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/0092-8674(94)90131-7","article-title":"Hydrogen peroxide mediates amyloid beta protein toxicity","volume":"77","author":"Behl","year":"1994","journal-title":"Cell"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0080","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1358\/dnp.2010.23.8.1500435","article-title":"The rise and fall of Dimebon","volume":"23","author":"Bezprozvanny","year":"2010","journal-title":"Drug News Perspect"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0085","doi-asserted-by":"crossref","first-page":"949","DOI":"10.3233\/JAD-2012-120178","article-title":"Latrepirdine (Dimebon) enhances autophagy and reduces intracellular GFP-Abeta42 levels in yeast","volume":"32","author":"Bharadwaj","year":"2012","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0090","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1080\/03007995.2020.12102584","article-title":"Effects of acetyl-l-carnitine in Alzheimer\u2019s disease patients unresponsive to acetylcholinesterase inhibitors","volume":"19","author":"Bianchetti","year":"2003","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0095","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0197-4580(01)00314-1","article-title":"Cytochrome c oxidase and mitochondrial F1F0-ATPase (ATP synthase) activities in platelets and brain from patients with Alzheimer\u2019s disease","volume":"23","author":"Bosetti","year":"2002","journal-title":"Neurobiol Aging"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0100","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.neurobiolaging.2010.08.016","article-title":"Elevated 4-hydroxyhexenal in Alzheimer\u2019s disease (AD) progression","volume":"33","author":"Bradley","year":"2012","journal-title":"Neurobiol Aging"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0105","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.bbr.2014.06.001","article-title":"Partial rescue of memory deficits induced by calorie restriction in a mouse model of tau deposition","volume":"271","author":"Brownlow","year":"2014","journal-title":"Behav Brain Res"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0110","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/ana.20474","article-title":"Mitochondrial abnormalities in Alzheimer brain: mechanistic implications","volume":"57","author":"Bubber","year":"2005","journal-title":"Ann Neurol"},{"issue":"Suppl 1","key":"10.1016\/B978-0-12-802173-6.00018-6_bib0115","first-page":"S277","article-title":"The metal theory of Alzheimer\u2019s disease","volume":"33","author":"Bush","year":"2013","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0120","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.nurt.2008.05.001","article-title":"Therapeutics for Alzheimer\u2019s disease based on the metal hypothesis","volume":"5","author":"Bush","year":"2008","journal-title":"Neurotherapeutics"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0125","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0197-4580(03)00033-2","article-title":"Cytochrome c oxidase is decreased in Alzheimer\u2019s disease platelets","volume":"25","author":"Cardoso","year":"2004","journal-title":"Neurobiol Aging"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0130","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.devcel.2007.11.019","article-title":"Chemical inhibition of the mitochondrial division dynamin reveals its role in Bax\/Bak-dependent mitochondrial outer membrane permeabilization","volume":"14","author":"Cassidy-Stone","year":"2008","journal-title":"Dev Cell"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0135","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.bcp.2014.01.009","article-title":"The complexities of the pathology\u2013pathogenesis relationship in Alzheimer disease","volume":"88","author":"Castellani","year":"2014","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0140","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1016\/S0891-5849(99)00016-7","article-title":"Is increased redox-active iron in Alzheimer disease a failure of the copper-binding protein ceruloplasmin?","volume":"26","author":"Castellani","year":"1999","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0145","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0891-5849(01)00570-6","article-title":"Active glycation in neurofibrillary pathology of Alzheimer disease: N(epsilon)-(carboxymethyl) lysine and hexitol-lysine","volume":"31","author":"Castellani","year":"2001","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0150","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.3390\/ijms10031386","article-title":"Molecular pathogenesis of Alzheimer\u2019s disease: reductionist versus expansionist approaches","volume":"10","author":"Castellani","year":"2009","journal-title":"Int J Mol Sci"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0155","doi-asserted-by":"crossref","first-page":"182303","DOI":"10.1155\/2014\/182303","article-title":"The roles of biomarkers of oxidative stress and antioxidant in Alzheimer\u2019s disease: a systematic review","volume":"2014","author":"Chang","year":"2014","journal-title":"BioMed Res Intl"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0160","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s12264-013-1423-y","article-title":"Oxidative stress in Alzheimer\u2019s disease","volume":"30","author":"Chen","year":"2014","journal-title":"Neurosci Bull"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0165","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.freeradbiomed.2005.06.025","article-title":"Potential markers of oxidative stress in stroke","volume":"39","author":"Cherubini","year":"2005","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0170","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1126\/science.1171091","article-title":"S-nitrosylation of Drp1 mediates beta-amyloid-related mitochondrial fission and neuronal injury","volume":"324","author":"Cho","year":"2009","journal-title":"Science"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0175","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.jprot.2010.12.012","article-title":"Early dysregulation of the mitochondrial proteome in a mouse model of Alzheimer\u2019s disease","volume":"74","author":"Chou","year":"2011","journal-title":"J Proteomics"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0180","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/B978-0-12-800149-3.00005-6","article-title":"Genetics of Alzheimer\u2019s disease","volume":"87","author":"Chouraki","year":"2014","journal-title":"Adv Genet"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0185","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.exger.2012.07.006","article-title":"Alzheimer disease as a vascular disorder: where do mitochondria fit?","volume":"47","author":"Correia","year":"2012","journal-title":"Exp Gerontol"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0190","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/jnc.12406","article-title":"Is exercise-in-a-bottle likely to proffer new insights into Alzheimer\u2019s disease?","volume":"127","author":"Correia","year":"2013","journal-title":"J Neurochem"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0195","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jns.2011.11.001","article-title":"Peripheral markers in neurodegenerative patients and their first-degree relatives","volume":"314","author":"Cristalli","year":"2012","journal-title":"J Neurol Sci"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0200","doi-asserted-by":"crossref","first-page":"20466","DOI":"10.1074\/jbc.M100175200","article-title":"Alzheimer\u2019s disease amyloid-beta binds copper and zinc to generate an allosterically ordered membrane-penetrating structure containing superoxide dismutase-like subunits","volume":"276","author":"Curtain","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0205","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1074\/jbc.M205455200","article-title":"Metal ions, pH, and cholesterol regulate the interactions of Alzheimer\u2019s disease amyloid-beta peptide with membrane lipid","volume":"278","author":"Curtain","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0210","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1586\/14737175.2015.955853","article-title":"Strategy to reduce free radical species in Alzheimer\u2019s disease: an update of selected antioxidants","volume":"15","author":"Di Domenico","year":"2015","journal-title":"Expert Rev Neurotherapeutics"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0215","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0140-6736(08)61074-0","article-title":"Effect of Dimebon on cognition, activities of daily living, behaviour, and global function in patients with mild-to-moderate Alzheimer\u2019s disease: a randomised, double-blind, placebo-controlled study","volume":"372","author":"Doody","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0220","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1532-5415.2007.01543.x","article-title":"Melatonin and bright-light treatment for rest\u2013activity disruption in institutionalized patients with Alzheimer\u2019s disease","volume":"56","author":"Dowling","year":"2008","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0225","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s11357-013-9592-1","article-title":"Activation of sirtuin 1 attenuates cerebral ventricular streptozotocin-induced tau hyperphosphorylation and cognitive injuries in rat hippocampi","volume":"36","author":"Du","year":"2014","journal-title":"Age"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0230","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.2174\/1389450111007011281","article-title":"Potential therapeutic targets for neurodegenerative diseases: lessons learned from calorie restriction","volume":"11","author":"Duan","year":"2010","journal-title":"Curr Drug Targets"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0235","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.freeradbiomed.2010.11.026","article-title":"Neuroprotective strategies involving ROS in Alzheimer disease","volume":"51","author":"Dumont","year":"2011","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0240","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3233\/JAD-2011-110209","article-title":"Coenzyme Q10 decreases amyloid pathology and improves behavior in a transgenic mouse model of Alzheimer\u2019s disease","volume":"27","author":"Dumont","year":"2011","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0245","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3233\/JAD-2012-120310","article-title":"Dimebon ameliorates amyloid-beta induced impairments of mitochondrial form and function","volume":"31","author":"Eckert","year":"2012","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0250","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3233\/JAD-2011-111190","article-title":"Behavioral improvement after chronic administration of coenzyme Q10 in P301S transgenic mice","volume":"28","author":"Elipenahli","year":"2012","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0255","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.bbrc.2008.12.071","article-title":"Rosiglitazone reverses memory decline and hippocampal glucocorticoid receptor down-regulation in an Alzheimer\u2019s disease mouse model","volume":"379","author":"Escribano","year":"2009","journal-title":"Biochem Bioph Res Co"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0260","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/nyas.12424","article-title":"Alzheimer\u2019s disease research and development: a call for a new research roadmap","volume":"1313","author":"Feldman","year":"2014","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0265","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.freeradbiomed.2005.08.014","article-title":"Early melatonin supplementation alleviates oxidative stress in a transgenic mouse model of Alzheimer\u2019s disease","volume":"40","author":"Feng","year":"2006","journal-title":"Free Radical Biol Med"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0270","doi-asserted-by":"crossref","first-page":"4540","DOI":"10.2174\/09298673113209990146","article-title":"Chemistry and pharmacological properties of some natural and synthetic antioxidants for heavy metal toxicity","volume":"20","author":"Flora","year":"2013","journal-title":"Curr Med Chem"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0275","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.bbadis.2013.11.009","article-title":"Inhibition of ERK-DLP1 signaling and mitochondrial division alleviates mitochondrial dysfunction in Alzheimer\u2019s disease cybrid cell","volume":"1842","author":"Gan","year":"2014","journal-title":"Biochimica et Biophysica Acta"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0280","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1111\/j.1471-4159.2007.04613.x","article-title":"Curcumin labels amyloid pathology in vivo, disrupts existing plaques, and partially restores distorted neurites in an Alzheimer mouse model","volume":"102","author":"Garcia-Alloza","year":"2007","journal-title":"J Neurochem"},{"issue":"1124","key":"10.1016\/B978-0-12-802173-6.00018-6_bib0285","first-page":"e13","article-title":"Melatonin plus physical exercise are highly neuroprotective in the 3xTg-AD mouse","volume":"33","author":"Garcia-Mesa","year":"2012","journal-title":"Neurobiol Aging"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0290","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/JGP.0b013e318187de18","article-title":"Melatonin fails to improve sleep or agitation in double-blind randomized placebo-controlled trial of institutionalized patients with Alzheimer disease","volume":"17","author":"Gehrman","year":"2009","journal-title":"Am J Geriat Psychiat"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0295","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1124\/mol.106.033845","article-title":"The thiazolidinedione pioglitazone alters mitochondrial function in human neuron-like cells","volume":"71","author":"Ghosh","year":"2007","journal-title":"Mol Pharmacol"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0300","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3389\/fnagi.2014.00095","article-title":"Resveratrol and Alzheimer\u2019s disease: message in a bottle on red wine and cognition","volume":"6","author":"Granzotto","year":"2014","journal-title":"Frontiers Aging Neurosci"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0305","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0167-4943(01)00104-2","article-title":"Alpha-lipoic acid as a new treatment option for Alzheimer [corrected] type dementia","volume":"32","author":"Hager","year":"2001","journal-title":"Arch Gerontol Geriat"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0310","first-page":"189","article-title":"Alpha-lipoic acid as a new treatment option for Alzheimer\u2019s disease\u2014a 48\u00a0months follow-up analysis","author":"Hager","year":"2007","journal-title":"J Neur Tr S"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0315","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1182\/blood.V92.9.3007","article-title":"Inside the neutrophil phagosome: oxidants, myeloperoxidase, and bacterial killing","volume":"92","author":"Hampton","year":"1998","journal-title":"Blood"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0320","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1532-5415.2009.02067.x","article-title":"Pioglitazone improved cognition in a pilot study on patients with Alzheimer\u2019s disease and mild cognitive impairment with diabetes mellitus","volume":"57","author":"Hanyu","year":"2009","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0325","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1179\/147683009X423364","article-title":"Antioxidants and cognitive training interact to affect oxidative stress and memory in APP\/PSEN1 mice","volume":"12","author":"Harrison","year":"2009","journal-title":"Nutr Neurosci"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0330","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1523\/JNEUROSCI.21-09-03017.2001","article-title":"Mitochondrial abnormalities in Alzheimer\u2019s disease","volume":"21","author":"Hirai","year":"2001","journal-title":"J Neurosci"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0335","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.neuron.2010.09.039","article-title":"Molecular motors in neurons: transport mechanisms and roles in brain function, development, and disease","volume":"68","author":"Hirokawa","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0340","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S0140-6736(08)61075-2","article-title":"Long-term effects of Abeta42 immunisation in Alzheimer\u2019s disease: follow-up of a randomised, placebo-controlled phase I trial","volume":"372","author":"Holmes","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0345","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/j.neurobiolaging.2007.03.004","article-title":"Longitudinal MRI findings from the vitamin E and donepezil treatment study for MCI","volume":"29","author":"Jack","year":"2008","journal-title":"Neurobiol Aging"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0350","doi-asserted-by":"crossref","first-page":"14708","DOI":"10.1074\/jbc.M611463200","article-title":"Interaction of the mitochondria-targeted antioxidant MitoQ with phospholipid bilayers and ubiquinone oxidoreductases","volume":"282","author":"James","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0360","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.mcn.2008.07.010","article-title":"Nuclear factor erythroid 2-related factor 2 protects against beta amyloid","volume":"39","author":"Kanninen","year":"2008","journal-title":"Mol Cell Neurosci"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0365","doi-asserted-by":"crossref","first-page":"16505","DOI":"10.1073\/pnas.0908397106","article-title":"Intrahippocampal injection of a lentiviral vector expressing Nrf2 improves spatial learning in a mouse model of Alzheimer\u2019s disease","volume":"106","author":"Kanninen","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0370","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/nrd3505","article-title":"The amyloid cascade hypothesis for Alzheimer\u2019s disease: an appraisal for the development of therapeutics","volume":"10","author":"Karran","year":"2011","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0375","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.clinbiochem.2006.02.002","article-title":"Association between apolipoprotein E polymorphism and coronary artery disease in the Kermanshah population in Iran","volume":"39","author":"Kharrazi","year":"2006","journal-title":"Clin Biochem"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0380","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.abb.2007.03.034","article-title":"Selective degradation of mitochondria by mitophagy","volume":"462","author":"Kim","year":"2007","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0385","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1111\/j.1471-4159.1992.tb09439.x","article-title":"Brain cytochrome oxidase in Alzheimer\u2019s disease","volume":"59","author":"Kish","year":"1992","journal-title":"J Neurochem"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0390","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1476-5381.2010.00656.x","article-title":"The metabolic enhancer piracetam ameliorates the impairment of mitochondrial function and neurite outgrowth induced by beta-amyloid peptide","volume":"160","author":"Kurz","year":"2010","journal-title":"Brit J Pharmacol"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0395","article-title":"Improved mitochondrial function in brain aging and Alzheimer disease\u2014the new mechanism of action of the old metabolic enhancer piracetam","volume":"4","author":"Leuner","year":"2010","journal-title":"Frontiers Neurosci"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0400","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/jnc.12394","article-title":"Lactate administration reproduces specific brain and liver exercise-related changes","volume":"127","author":"Lezi","year":"2013","journal-title":"J Neurochem"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0405","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/biof.5520250111","article-title":"Coenzyme Q10 protects SHSY5Y neuronal cells from beta amyloid toxicity and oxygen-glucose deprivation by inhibiting the opening of the mitochondrial permeability transition pore","volume":"25","author":"Li","year":"2005","journal-title":"BioFactors"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0410","doi-asserted-by":"crossref","first-page":"8370","DOI":"10.1523\/JNEUROSCI.21-21-08370.2001","article-title":"The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse","volume":"21","author":"Lim","year":"2001","journal-title":"J Neurosci"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0415","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1073\/pnas.0510452103","article-title":"Calorie restriction induces mitochondrial biogenesis and bioenergetic efficiency","volume":"103","author":"Lopez-Lluch","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0420","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0022-510X(98)00092-6","article-title":"Copper, iron and zinc in Alzheimer\u2019s disease senile plaques","volume":"158","author":"Lovell","year":"1998","journal-title":"J Neurol Sci"},{"issue":"Suppl 2","key":"10.1016\/B978-0-12-802173-6.00018-6_bib0425","doi-asserted-by":"crossref","first-page":"S609","DOI":"10.3233\/JAD-2010-100564","article-title":"Mitochondria-targeted antioxidants protect against amyloid-beta toxicity in Alzheimer\u2019s disease neurons","volume":"20","author":"Manczak","year":"2010","journal-title":"J Alzheimer\u2019s Dis"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0430","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/ana.20629","article-title":"Lipid peroxidation is an early event in the brain in amnestic mild cognitive impairment","volume":"58","author":"Markesbery","year":"2005","journal-title":"Ann Neurol"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0435","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.neuroscience.2015.06.027","article-title":"Physical exercise improves brain cortex and cerebellum mitochondrial bioenergetics and alters apoptotic, dynamic and auto(mito)phagy markers","volume":"301","author":"Marques-Aleixo","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0440","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1111\/j.1471-4159.1993.tb07436.x","article-title":"Brain alpha-ketoglutarate dehydrogenase complex activity in Alzheimer\u2019s disease","volume":"61","author":"Mastrogiacomo","year":"1993","journal-title":"J Neurochem"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0445","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1046\/j.1471-4159.2003.01654.x","article-title":"Melatonin increases survival and inhibits oxidative and amyloid pathology in a transgenic model of Alzheimer\u2019s disease","volume":"85","author":"Matsubara","year":"2003","journal-title":"J Neurochem"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0450","doi-asserted-by":"crossref","first-page":"15703","DOI":"10.1523\/JNEUROSCI.0552-11.2011","article-title":"The mitochondria-targeted antioxidant MitoQ prevents loss of spatial memory retention and early neuropathology in a transgenic mouse model of Alzheimer\u2019s disease","volume":"31","author":"McManus","year":"2011","journal-title":"J Neurosci"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0455","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.neurobiolaging.2004.07.016","article-title":"Oxidative DNA damage in peripheral leukocytes of mild cognitive impairment and AD patients","volume":"26","author":"Migliore","year":"2005","journal-title":"Neurobiol Aging"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0460","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1126\/science.327.5971.1309","article-title":"Pharmacology: the puzzling rise and fall of a dark-horse Alzheimer\u2019s drug","volume":"327","author":"Miller","year":"2010","journal-title":"Science"},{"issue":"Suppl 1","key":"10.1016\/B978-0-12-802173-6.00018-6_bib0465","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1080\/13547500500216546","article-title":"F2-isoprostanes as markers of oxidative stress in vivo: an overview","volume":"10","author":"Milne","year":"2005","journal-title":"Biomarkers"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0470","doi-asserted-by":"crossref","first-page":"4232","DOI":"10.1523\/JNEUROSCI.6248-09.2010","article-title":"Mitofusin 2 is necessary for transport of axonal mitochondria and interacts with the Miro\/Milton complex","volume":"30","author":"Misko","year":"2010","journal-title":"J Neurosci"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0475","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/00004850-200303000-00001","article-title":"Meta-analysis of double blind randomized controlled clinical trials of acetyl-L-carnitine versus placebo in the treatment of mild cognitive impairment and mild Alzheimer\u2019s disease","volume":"18","author":"Montgomery","year":"2003","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0480","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.expneurol.2005.07.012","article-title":"CoQ10 therapy attenuates amyloid beta-peptide toxicity in brain mitochondria isolated from aged diabetic rats","volume":"196","author":"Moreira","year":"2005","journal-title":"Exp Neurol"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0485","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/01.jnen.0000240476.73532.b0","article-title":"Autophagocytosis of mitochondria is prominent in Alzheimer disease","volume":"66","author":"Moreira","year":"2007","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0490","doi-asserted-by":"crossref","first-page":"614","DOI":"10.4161\/auto.4872","article-title":"Increased autophagic degradation of mitochondria in Alzheimer disease","volume":"3","author":"Moreira","year":"2007","journal-title":"Autophagy"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0495","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3233\/JAD-2007-12210","article-title":"Lipoic acid and N-acetyl cysteine decrease mitochondrial-related oxidative stress in Alzheimer disease patient fibroblasts","volume":"12","author":"Moreira","year":"2007","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0500","doi-asserted-by":"crossref","first-page":"492","DOI":"10.2174\/187152709789824651","article-title":"Mitochondria as a therapeutic target in Alzheimer\u2019s disease and diabetes","volume":"8","author":"Moreira","year":"2009","journal-title":"CNS Neurol Disord-Dr"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0505","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.bbadis.2009.10.007","article-title":"Mitochondria: a therapeutic target in neurodegeneration","volume":"1802","author":"Moreira","year":"2010","journal-title":"Biochimica et Biophysica Acta"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0510","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1146\/annurev.pharmtox.47.120505.105110","article-title":"Targeting antioxidants to mitochondria by conjugation to lipophilic cations","volume":"47","author":"Murphy","year":"2007","journal-title":"Annu Rev Pharmacol"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0515","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1046\/j.1471-4159.1994.63062179.x","article-title":"Cortical cytochrome oxidase activity is reduced in Alzheimer\u2019s disease","volume":"63","author":"Mutisya","year":"1994","journal-title":"J Neurochem"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0520","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.freeradbiomed.2014.03.003","article-title":"The mitochondria-targeted antioxidant MitoQ extends lifespan and improves healthspan of a transgenic Caenorhabditis elegans model of Alzheimer disease","volume":"71","author":"Ng","year":"2014","journal-title":"Free Radical Biol Med"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0525","doi-asserted-by":"crossref","first-page":"9287","DOI":"10.1523\/JNEUROSCI.3348-08.2008","article-title":"Complete rescue of cerebrovascular function in aged Alzheimer\u2019s disease transgenic mice by antioxidants and pioglitazone, a peroxisome proliferator-activated receptor gamma agonist","volume":"28","author":"Nicolakakis","year":"2008","journal-title":"J Neurosci"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0530","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1523\/JNEUROSCI.19-06-01959.1999","article-title":"RNA oxidation is a prominent feature of vulnerable neurons in Alzheimer\u2019s disease","volume":"19","author":"Nunomura","year":"1999","journal-title":"J Neurosci"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0535","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1093\/jnen\/59.11.1011","article-title":"Neuronal oxidative stress precedes amyloid-beta deposition in Down syndrome","volume":"59","author":"Nunomura","year":"2000","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0540","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1093\/jnen\/60.8.759","article-title":"Oxidative damage is the earliest event in Alzheimer disease","volume":"60","author":"Nunomura","year":"2001","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0545","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1097\/01.jnen.0000228136.58062.bf","article-title":"Involvement of oxidative stress in Alzheimer disease","volume":"65","author":"Nunomura","year":"2006","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0550","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.2174\/092986707782794078","article-title":"Oxidative RNA damage and neurodegeneration","volume":"14","author":"Nunomura","year":"2007","journal-title":"Curr Med Chem"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0555","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s12640-012-9331-x","article-title":"Oxidative damage to RNA in aging and neurodegenerative disorders","volume":"22","author":"Nunomura","year":"2012","journal-title":"Neurotox Res"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0560","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/NEN.0b013e318248e614","article-title":"The earliest stage of cognitive impairment in transition from normal aging to Alzheimer disease is marked by prominent RNA oxidation in vulnerable neurons","volume":"71","author":"Nunomura","year":"2012","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0565","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2174\/156720510790691100","article-title":"From anti-allergic to anti-Alzheimer\u2019s: molecular pharmacology of Dimebon","volume":"7","author":"Okun","year":"2010","journal-title":"Curr Alzheimer Res"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0570","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1600-079X.2009.00692.x","article-title":"Protection against cognitive deficits and markers of neurodegeneration by long-term oral administration of melatonin in a transgenic model of Alzheimer disease","volume":"47","author":"Olcese","year":"2009","journal-title":"J Pineal Res"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0575","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s13024-015-0027-6","article-title":"Prophylactic melatonin significantly reduces Alzheimer\u2019s neuropathology and associated cognitive deficits independent of antioxidant pathways in AbetaPP(swe)\/PS1 mice","volume":"10","author":"O\u2019Neal-Moffitt","year":"2015","journal-title":"Mol Neurodegener"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0580","doi-asserted-by":"crossref","first-page":"40302","DOI":"10.1074\/jbc.M206428200","article-title":"Metalloenzyme-like activity of Alzheimer\u2019s disease beta-amyloid: Cu-dependent catalytic conversion of dopamine, cholesterol, and biological reducing agents to neurotoxic H(2)O(2)","volume":"277","author":"Opazo","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0585","doi-asserted-by":"crossref","first-page":"e68612","DOI":"10.1371\/journal.pone.0068612","article-title":"Pioglitazone improves reversal learning and exerts mixed cerebrovascular effects in a mouse model of Alzheimer\u2019s disease with combined amyloid-beta and cerebrovascular pathology","volume":"8","author":"Papadopoulos","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0590","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1523\/JNEUROSCI.17-05-01683.1997","article-title":"Melatonin prevents death of neuroblastoma cells exposed to the Alzheimer amyloid peptide","volume":"17","author":"Pappolla","year":"1997","journal-title":"J Neurosci"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0595","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1212\/WNL.44.2.339","article-title":"ApoE epsilon 4 allelic association with Alzheimer\u2019s disease: independent confirmation using denaturing gradient gel electrophoresis","volume":"44","author":"Peacock","year":"1994","journal-title":"Neurology"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0600","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.bcp.2014.01.028","article-title":"Plaques and tangles: birthmarks of the aging soul: preface","volume":"88","author":"Perry","year":"2014","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0605","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1007\/s00401-003-0761-7","article-title":"Oxidative damage in the olfactory system in Alzheimer\u2019s disease","volume":"106","author":"Perry","year":"2003","journal-title":"Acta Neuropathol"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0610","doi-asserted-by":"crossref","first-page":"427318","DOI":"10.1155\/2014\/427318","article-title":"Oxidative stress in Alzheimer\u2019s disease: why did antioxidant therapy fail?","volume":"2014","author":"Persson","year":"2014","journal-title":"Oxidative Med Cell Longevity"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0615","doi-asserted-by":"crossref","first-page":"517","DOI":"10.3233\/JAD-2002-4608","article-title":"Plasma susceptibility to free radical-induced antioxidant consumption and lipid peroxidation is increased in very old subjects with Alzheimer disease","volume":"4","author":"Polidori","year":"2002","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0620","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.neuint.2004.07.008","article-title":"Proteomic analysis of specific brain proteins in aged SAMP8 mice treated with alpha-lipoic acid: implications for aging and age-related neurodegenerative disorders","volume":"46","author":"Poon","year":"2005","journal-title":"Neurochem Int"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0625","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1007\/s11357-012-9489-4","article-title":"Dietary resveratrol prevents Alzheimer\u2019s markers and increases life span in SAMP8","volume":"35","author":"Porquet","year":"2013","journal-title":"Age"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0630","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1001\/archneurol.2008.588","article-title":"PGC-1alpha expression decreases in the Alzheimer disease brain as a function of dementia","volume":"66","author":"Qin","year":"2009","journal-title":"Arch Neurol"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0635","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.neurobiolaging.2005.12.014","article-title":"Chronic dietary alpha-lipoic acid reduces deficits in hippocampal memory of aged Tg2576 mice","volume":"28","author":"Quinn","year":"2007","journal-title":"Neurobiol Aging"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0640","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1089\/ars.2012.5084","article-title":"Copper and iron homeostasis in plants: the challenges of oxidative stress","volume":"19","author":"Ravet","year":"2013","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0645","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.bbadis.2011.10.011","article-title":"Abnormal mitochondrial dynamics and synaptic degeneration as early events in Alzheimer\u2019s disease: implications to mitochondria-targeted antioxidant therapeutics","volume":"1822","author":"Reddy","year":"2012","journal-title":"Biochimica et Biophysica Acta"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0650","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1016\/j.freeradbiomed.2008.03.012","article-title":"Brain oxidative stress in a triple-transgenic mouse model of Alzheimer disease","volume":"44","author":"Resende","year":"2008","journal-title":"Free Radical Biol Med"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0655","doi-asserted-by":"crossref","first-page":"e12359","DOI":"10.1371\/journal.pone.0012359","article-title":"Ginkgo biloba extract ameliorates oxidative phosphorylation performance and rescues abeta-induced failure","volume":"5","author":"Rhein","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0660","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/S0197-4580(03)00031-9","article-title":"Plasma antioxidants are similarly depleted in mild cognitive impairment and in Alzheimer\u2019s disease","volume":"24","author":"Rinaldi","year":"2003","journal-title":"Neurobiol Aging"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0665","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/sj.tpj.6500369","article-title":"Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer\u2019s disease","volume":"6","author":"Risner","year":"2006","journal-title":"Pharmacogenomics J"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0670","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3233\/JAD-150161","article-title":"Melatonin attenuates memory impairment, amyloid-beta accumulation, and neurodegeneration in a rat model of sporadic Alzheimer\u2019s disease","volume":"47","author":"Rudnitskaya","year":"2015","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0675","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1515\/revneuro-2014-0046","article-title":"Oxidative stress and genetic markers of suboptimal antioxidant defense in the aging brain: a theoretical review","volume":"25","author":"Salminen","year":"2014","journal-title":"Rev Neurosci"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0680","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1056\/NEJM199704243361704","article-title":"A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer\u2019s disease. The Alzheimer\u2019s Disease Cooperative Study","volume":"336","author":"Sano","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0685","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1016\/j.neurobiolaging.2009.10.009","article-title":"Efficacy of PPAR-gamma agonist pioglitazone in mild Alzheimer disease","volume":"32","author":"Sato","year":"2011","journal-title":"Neurobiol Aging"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0690","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1046\/j.1471-4159.1997.68052092.x","article-title":"4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer\u2019s disease","volume":"68","author":"Sayre","year":"1997","journal-title":"J Neurochem"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0695","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1038\/sj.emboj.7601623","article-title":"Reactive oxygen species are essential for autophagy and specifically regulate the activity of Atg4","volume":"26","author":"Scherz-Shouval","year":"2007","journal-title":"EMBO J"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0700","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2013.07.003","article-title":"SnapShot: pathobiology of Alzheimer\u2019s disease","volume":"154","author":"Selkoe","year":"2013","journal-title":"Cell"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0705","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s12017-013-8272-8","article-title":"Monitoring of neuronal loss in the hippocampus of Abeta-injected rat: autophagy, mitophagy, and mitochondrial biogenesis stand against apoptosis","volume":"16","author":"Shaerzadeh","year":"2014","journal-title":"Neuromol Med"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0710","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1016\/S0024-3205(02)02083-0","article-title":"Chronic treatment with trans resveratrol prevents intracerebroventricular streptozotocin induced cognitive impairment and oxidative stress in rats","volume":"71","author":"Sharma","year":"2002","journal-title":"Life Sci"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0715","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1083\/jcb.201312123","article-title":"Mitochondrial trafficking and anchoring in neurons: new insight and implications","volume":"204","author":"Sheng","year":"2014","journal-title":"J Cell Biol"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0720","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/nrn3156","article-title":"Mitochondrial transport in neurons: impact on synaptic homeostasis and neurodegeneration","volume":"13","author":"Sheng","year":"2012","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0725","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.1471-4159.2011.07581.x","article-title":"Impaired mitochondrial biogenesis contributes to mitochondrial dysfunction in Alzheimer\u2019s disease","volume":"120","author":"Sheng","year":"2012","journal-title":"J Neurochem"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0730","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1432-1033.1993.tb18025.x","article-title":"Strategies of antioxidant defense","volume":"215","author":"Sies","year":"1993","journal-title":"Eur J Biochem\/FEBS"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0735","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1091\/mbc.12.8.2245","article-title":"Dynamin-related protein Drp1 is required for mitochondrial division in mammalian cells","volume":"12","author":"Smirnova","year":"2001","journal-title":"Mol Biol Cell"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0740","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3233\/JAD-2003-5404","article-title":"Elevation of oxidative free radicals in Alzheimer\u2019s disease models can be attenuated by Ginkgo biloba extract EGb 761","volume":"5","author":"Smith","year":"2003","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0745","doi-asserted-by":"crossref","first-page":"5710","DOI":"10.1073\/pnas.91.12.5710","article-title":"Advanced Maillard reaction end products are associated with Alzheimer disease pathology","volume":"91","author":"Smith","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0750","first-page":"42","article-title":"Heme oxygenase-1 is associated with the neurofibrillary pathology of Alzheimer\u2019s disease","volume":"145","author":"Smith","year":"1994","journal-title":"Am J Pathol"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0755","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/0166-2236(95)93897-7","article-title":"Radical AGEing in Alzheimer\u2019s disease","volume":"18","author":"Smith","year":"1995","journal-title":"Trends Neurosci"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0760","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.1046\/j.1471-4159.1995.64062660.x","article-title":"Carbonyl-related posttranslational modification of neurofilament protein in the neurofibrillary pathology of Alzheimer\u2019s disease","volume":"64","author":"Smith","year":"1995","journal-title":"J Neurochem"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0765","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1523\/JNEUROSCI.17-08-02653.1997","article-title":"Widespread peroxynitrite-mediated damage in Alzheimer\u2019s disease","volume":"17","author":"Smith","year":"1997","journal-title":"J Neurosci"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0770","doi-asserted-by":"crossref","first-page":"9866","DOI":"10.1073\/pnas.94.18.9866","article-title":"Iron accumulation in Alzheimer disease is a source of redox-generated free radicals","volume":"94","author":"Smith","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0775","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.nbd.2004.10.021","article-title":"Role of mitochondria in neuronal cell death induced by oxidative stress: neuroprotection by coenzyme Q10","volume":"18","author":"Somayajulu","year":"2005","journal-title":"Neurobiol Dis"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0780","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1212\/WNL.59.8.1153","article-title":"Elevation of serum copper levels in Alzheimer\u2019s disease","volume":"59","author":"Squitti","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0785","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1038\/mp.2012.106","article-title":"Latrepirdine improves cognition and arrests progression of neuropathology in an Alzheimer\u2019s mouse model","volume":"18","author":"Steele","year":"2013","journal-title":"Mol Psychiatr"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0790","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/jpi.12248","article-title":"Melatonin attenuates impairments of structural hippocampal neuroplasticity in OXYS rats during active progression of Alzheimer\u2019s disease-like pathology","volume":"59","author":"Stefanova","year":"2015","journal-title":"J Pineal Res"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0795","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1152\/japplphysiol.00343.2011","article-title":"Exercise training increases mitochondrial biogenesis in the brain","volume":"111","author":"Steiner","year":"2011","journal-title":"J Appl Physiol"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0800","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1042\/BST20130054","article-title":"Improvement of mitochondrial function and dynamics by the metabolic enhancer piracetam","volume":"41","author":"Stockburger","year":"2013","journal-title":"Biochem Soc T"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0805","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3233\/JAD-2007-11108","article-title":"Rosiglitazone induces mitochondrial biogenesis in mouse brain","volume":"11","author":"Strum","year":"2007","journal-title":"J Alzheimers Dis"},{"issue":"Suppl 1","key":"10.1016\/B978-0-12-802173-6.00018-6_bib0810","first-page":"S243","article-title":"Oxidative modification of brain proteins in Alzheimer\u2019s disease: perspective on future studies based on results of redox proteomics studies","volume":"33","author":"Sultana","year":"2013","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0815","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1096\/fj.03-0961fje","article-title":"Early vitamin E supplementation in young but not aged mice reduces Abeta levels and amyloid deposition in a transgenic model of Alzheimer\u2019s disease","volume":"18","author":"Sung","year":"2004","journal-title":"FASEB J"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0820","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3390\/ph2030150","article-title":"Mitochondrial medicine and the neurodegenerative mitochondriopathies","volume":"2","author":"Swerdlow","year":"2009","journal-title":"Pharmaceuticals"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0825","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1038\/nn0805-977","article-title":"The synaptic Abeta hypothesis of Alzheimer disease","volume":"8","author":"Tanzi","year":"2005","journal-title":"Nat Neurosci"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0830","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1212\/01.WNL.0000096376.03678.C1","article-title":"Idebenone treatment fails to slow cognitive decline in Alzheimer\u2019s disease","volume":"61","author":"Thal","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0835","doi-asserted-by":"crossref","first-page":"8972","DOI":"10.1523\/JNEUROSCI.20-24-08972.2000","article-title":"Inhibition of Krebs cycle enzymes by hydrogen peroxide: a key role of [alpha]-ketoglutarate dehydrogenase in limiting NADH production under oxidative stress","volume":"20","author":"Tretter","year":"2000","journal-title":"J Neurosci"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0840","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1089\/ars.2005.7.1101","article-title":"Differentiated Alzheimer\u2019s disease transmitochondrial cybrid cell lines exhibit reduced organelle movement","volume":"7","author":"Trimmer","year":"2005","journal-title":"Antioxid Redox Sign"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0845","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1212\/WNL.0000000000002035","article-title":"A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease","volume":"85","author":"Turner","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0850","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1089\/ars.2010.3779","article-title":"The interplay between mitochondrial dynamics and mitophagy","volume":"14","author":"Twig","year":"2011","journal-title":"Antioxid Redox Sign"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0855","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/sj.emboj.7601963","article-title":"Fission and selective fusion govern mitochondrial segregation and elimination by autophagy","volume":"27","author":"Twig","year":"2008","journal-title":"EMBO J"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0860","first-page":"529","article-title":"Exercise training acts as a therapeutic strategy for reduction of the pathogenic phenotypes for Alzheimer\u2019s disease in an NSE\/APPsw-transgenic model","volume":"22","author":"Um","year":"2008","journal-title":"Int J Mol Med"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0865","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.neures.2010.10.004","article-title":"Treadmill exercise represses neuronal cell death in an aged transgenic mouse model of Alzheimer\u2019s disease","volume":"69","author":"Um","year":"2011","journal-title":"Neurosci Res"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0870","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.mito.2006.10.004","article-title":"Impaired platelet mitochondrial activity in Alzheimer\u2019s disease and mild cognitive impairment","volume":"6","author":"Valla","year":"2006","journal-title":"Mitochondrion"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0875","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1177\/1533317511418956","article-title":"Six-month walking program changes cognitive and ADL performance in patients with Alzheimer","volume":"26","author":"Venturelli","year":"2011","journal-title":"Am J Alzheimer\u2019s Dis"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0880","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1096\/fj.04-3182fje","article-title":"Caloric restriction attenuates beta-amyloid neuropathology in a mouse model of Alzheimer\u2019s disease","volume":"19","author":"Wang","year":"2005","journal-title":"FASEB J"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0885","doi-asserted-by":"crossref","first-page":"19318","DOI":"10.1073\/pnas.0804871105","article-title":"Amyloid-beta overproduction causes abnormal mitochondrial dynamics via differential modulation of mitochondrial fission\/fusion proteins","volume":"105","author":"Wang","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0890","doi-asserted-by":"crossref","first-page":"9090","DOI":"10.1523\/JNEUROSCI.1357-09.2009","article-title":"Impaired balance of mitochondrial fission and fusion in Alzheimer\u2019s disease","volume":"29","author":"Wang","year":"2009","journal-title":"J Neurosci"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0895","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1750-1326-6-7","article-title":"Preclinical study of Dimebon on beta-amyloid-mediated neuropathology in Alzheimer\u2019s disease","volume":"6","author":"Wang","year":"2011","journal-title":"Mol Neurodegener"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0900","first-page":"950","article-title":"Preserved cognition in patients with early Alzheimer disease and amnestic mild cognitive impairment during treatment with rosiglitazone: a preliminary study","volume":"13","author":"Watson","year":"2005","journal-title":"Am J Geriat Psychiat"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0905","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1038\/nrm3013","article-title":"Mitochondrial fusion and fission in cell life and death","volume":"11","author":"Westermann","year":"2010","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0910","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.archger.2012.06.016","article-title":"Walking stabilizes cognitive functioning in Alzheimer\u2019s disease (AD) across one year","volume":"56","author":"Winchester","year":"2013","journal-title":"Arch Gerontol Geriat"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0915","doi-asserted-by":"crossref","first-page":"13102","DOI":"10.1523\/JNEUROSCI.3448-06.2006","article-title":"Amyloid-beta-induced pathological behaviors are suppressed by Ginkgo biloba extract EGb 761 and ginkgolides in transgenic Caenorhabditis elegans","volume":"26","author":"Wu","year":"2006","journal-title":"J Neurosci"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0920","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/j.neurobiolaging.2007.03.028","article-title":"Calorie restriction ameliorates neurodegenerative phenotypes in forebrain-specific presenilin-1 and presenilin-2 double knockout mice","volume":"29","author":"Wu","year":"2008","journal-title":"Neurobiol Aging"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0925","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.neuroscience.2013.10.011","article-title":"Inhibition of mitochondrial fission attenuates Abeta-induced microglia apoptosis","volume":"256","author":"Xie","year":"2014","journal-title":"Neuroscience"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0930","doi-asserted-by":"crossref","first-page":"5892","DOI":"10.1074\/jbc.M404751200","article-title":"Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo","volume":"280","author":"Yang","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0940","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/s12031-009-9297-1","article-title":"Coenzyme Q10 reduces beta-amyloid plaque in an APP\/PS1 transgenic mouse model of Alzheimer\u2019s disease","volume":"41","author":"Yang","year":"2010","journal-title":"J Mol Neurosci"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0945","doi-asserted-by":"crossref","first-page":"14670","DOI":"10.1073\/pnas.0903563106","article-title":"Mitochondrial bioenergetic deficit precedes Alzheimer\u2019s pathology in female mouse model of Alzheimer\u2019s disease","volume":"106","author":"Yao","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0950","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1093\/hmg\/ddv056","article-title":"Parkin-mediated mitophagy in mutant hAPP neurons and Alzheimer\u2019s disease patient brains","volume":"24","author":"Ye","year":"2015","journal-title":"Hum Mol Genet"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0955","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.brainresbull.2008.03.014","article-title":"Abundant expression of zinc transporters in the amyloid plaques of Alzheimer\u2019s disease brain","volume":"77","author":"Zhang","year":"2008","journal-title":"Brain Res Bull"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0960","doi-asserted-by":"crossref","first-page":"389","DOI":"10.3233\/JAD-2010-100174","article-title":"Dimebon (latrepirdine) enhances mitochondrial function and protects neuronal cells from death","volume":"21","author":"Zhang","year":"2010","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0965","doi-asserted-by":"crossref","first-page":"34682","DOI":"10.1074\/jbc.M402999200","article-title":"Cell-permeable peptide antioxidants targeted to inner mitochondrial membrane inhibit mitochondrial swelling, oxidative cell death, and reperfusion injury","volume":"279","author":"Zhao","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/B978-0-12-802173-6.00018-6_bib0970","doi-asserted-by":"crossref","first-page":"4207","DOI":"10.1096\/fj.09-135749","article-title":"Divalent metal transporter 1 is involved in amyloid precursor protein processing and Abeta generation","volume":"23","author":"Zheng","year":"2009","journal-title":"FASEB J"}],"container-title":["Developing Therapeutics for Alzheimer's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:B9780128021736000186?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:B9780128021736000186?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T01:57:26Z","timestamp":1656640646000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/B9780128021736000186"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"ISBN":["9780128021736"],"references-count":191,"URL":"https:\/\/doi.org\/10.1016\/b978-0-12-802173-6.00018-6","relation":{},"subject":[],"published":{"date-parts":[[2016]]}}}